Dec 20

LSD microdosing phase one clinical trial finds almost no side effects

Posted in: Today's Chili

Lysergic acid diethylamide, the psychedelic most commonly known as LSD, has shown promise as a potential treatment for the type of dementia known as Alzheimer’s disease. Life science company Eleusis has published the results from its phase 1 clinical trial involving LSD microdoses given to healthy adults over the course of a few weeks. The company monitored participants’ health during … Continue reading

No Responses to “LSD microdosing phase one clinical trial finds almost no side effects”

Post a Comment